Featured News

The FY20 spending package passed by Congress in December 2019 included the End Neglected Tropical Diseases Act, an important piece of legislation championed by GHTC that will strengthen US efforts to combat neglected tropical diseases. 

Learn More

PATH/Georgina Goodwin
Federal Spending Package Includes Bill to Boost Fight Against Neglected Tropical Diseases

Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.

Learn More

PATH/Eric Becker
GHTC Director quoted in Healio Infectious Disease News on the passage of the End NTDs Act
Healio Infectious Disease News quoted GHTC Director Jamie Bay Nishi in an article on the fiscal year 2020 spending packages, which includes the End NTDs Act.
Learn More

PATH/Patrick McKern
GHTC joins sign-on letter urging passage of FY20 Defense appropriations bill to protect funding for Defense Health Research Programs

GHTC joined 103 organizations in endorsing a letter to House and Senate leadership urging them to complete final negotiations on the fiscal year (FY) 2020 Defense Appropriations Act and pass the bill in order to protect funding for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs—which have historically supported research on global health issues like malaria and tuberculosis.

PDF

PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”

PDF

GHTC
Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View
View All News

PATH/Georgina Goodwin
Federal Spending Package Includes Bill to Boost Fight Against Neglected Tropical Diseases

Statement from Jamie Bay Nishi, Director of the Global Health Technologies Coalition, on the passage of the End Neglected Tropical Diseases Act, which was included in H.R. 1865, the Further Consolidated Appropriations Act, 2020, passed by Congress on December 19, 2019.

Learn More

Representatives Anna Eshoo and Mario Diaz-Balart and developers of the RTS,S malaria vaccine honored with GHTC Innovating for Impact Awards
GHTC yesterday honored Congresswoman Anna Eshoo (D-CA) and Congressman Mario Diaz-Balart (R-FL) for their leadership in supporting global health research and development (R&D) at its 2019 Innovating for Impact Awards, an initiative celebrating the US policymakers and partnerships driving global health innovation. GHTC also recognized the partnership that developed the RTS,S malaria vaccine—the world’s first malaria vaccine—for its efforts to advance this breakthrough technology.
Learn More

CDC/James Gathany
GHTC Statement on the Okayama Declaration of the G20 Health Ministers Meeting

The Global Health Technologies Coalition is greatly encouraged that yesterday’s Okayama Declaration from G20 Health Ministers contains strong support for investing in research and development initiatives to combat antimicrobial resistance and improve public health preparedness.

Learn More

PATH
US FDA Approves New TB Drug in Treatment to Cure Practically Incurable XDR-TB

Statement from Jamie Bay Nishi, Director, Global Health Technologies Coalition, on the US Food and Drug Administration’s approval of pretomanid, a new drug developed by the nonprofit TB Alliance.

Learn More

PATH/Mike Wang
President Signs Bill Reinforcing Fight Against Disease Threats. Focus Now Turns to Funding.

This legislation is an important step forward in strengthening our nation’s preparedness against global disease threats. We applaud the Administration and Congress for recognizing that protecting our nation’s health requires deploying BARDA’s unique capabilities to combat all hazards—not only chemical, biological, radiological and nuclear threats, but naturally occurring health threats as well.

View
View All Announcements
PATH/Patrick McKern
Research Roundup: Lack of R&D to combat AMR, first diagnostic for new virus from China, and WHO's urgent global health challenges for the decade

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: New coronavirus in China, app to detect and identify mosquitoes, and single dose of HIV antibodies can knock out virus in newborns

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Patrick McKern
Research Roundup: New drug push for three tropical diseases, new injection method improves TB vaccine efficacy, and breakthrough in developing antimalarials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Gabe Bienczycki
Research Roundup: FDA approves Ebola vaccine, experimental vaccine patch leaves a mark, masquerading virus for vaccine R&D

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Flickr/Paolo Rosa
Congress passes final FY20 spending packages marked by continued support for global health R&D
This week, months of tense negotiation between leaders in the Democratically-controlled US House of Representatives, the Republican-held Senate, and the White House concluded with the passage of two massive spending packages encompassing all federal government spending for fiscal year (FY) 2020 —nearly three months behind schedule.
Read More
View Breakthroughs Blog

PATH/Eric Becker
GHTC Director quoted in Healio Infectious Disease News on the passage of the End NTDs Act
Healio Infectious Disease News quoted GHTC Director Jamie Bay Nishi in an article on the fiscal year 2020 spending packages, which includes the End NTDs Act.
View

GHTC
Homeland Preparedness News covers GHTC awards

Homeland Preparedness News covered GHTC's 2019 Innovating for Impact Awards, which honored Representatives Anna Eshoo (D-CA) and Mario Diaz-Balart (R-FL).

View

PATH/Matthew Dakin
GHTC op-ed featured in The Hill

A commentary piece authored by GHTC Director Jamie Bay Nishi on the steady and substantial funding necessary to drive breakthrough innovations for global health threats was featured in The Hill

View

PATH/Wendy Stone
GHTC Director quoted in The Hill on Ebola vaccine development

The Hill quoted GHTC Director Jamie Bay Nishi in an article on Ebola vaccine development. 

View

PATH/Wendy Stone
GHTC Director quoted in The Verge on product development for emerging and infectious diseases

The Verge quoted GHTC Director Jamie Bay Nishi in an article on developing drugs and products amidst an outbreak.

View
View All GHTC in the Media

PATH/Patrick McKern
GHTC joins sign-on letter urging passage of FY20 Defense appropriations bill to protect funding for Defense Health Research Programs

GHTC joined 103 organizations in endorsing a letter to House and Senate leadership urging them to complete final negotiations on the fiscal year (FY) 2020 Defense Appropriations Act and pass the bill in order to protect funding for the Defense Health Research Programs, including the Congressionally Directed Medical Research Programs—which have historically supported research on global health issues like malaria and tuberculosis.

PDF

PATH/Eric Becker
GHTC joins sign-on letter urging swift passage of FY20 appropriations bills to avoid negative consequences for science and research

GHTC joined 162 organizations in endorsing a letter to House and Senate leadership urging them to complete work on the fiscal year (FY) 2020 appropriations bills as soon as possible, given that the uncertainty created by short-term continuing resolutions can have “severe consequences for science and research.”

PDF

USAID
GHTC sends letter urging Congressional appropriators to include report language on BARDA in F20 bill

GHTC sent a letter to House and Senate appropriators urging them to include in the final fiscal year (FY) 2020 Labor, Health and Human Services, Education, and Related Agencies bill report language emphasizing the role of the Biomedical Advanced Research and Development Authority (BARDA) in advancing R&D for naturally-occurring health threats and requesting a delineation of BARDA’s investments in this area in its annual five-year budget plan. 

PDF

PATH/Gabe Bienczycki
GHTC responds to RFI on National Vaccine Action Plan

GHTC submitted comments to a US Department of Health and Human Services request for information (RFI) on the 2020 National Vaccine Action Plan (NVP). GHTC’s submission encouraged the continuation of R&D objectives reflected in the 2010 NVP and recommended additional areas of focus including strengthening public-private partnerships, advancing regulatory science, ensuring sustainable financing for areas that lack commercial market demand, promoting access-centered R&D, and collaborating with international partners to strengthen laboratory and clinical trial capacity.

PDF

National Institute of Allergy and Infectious Diseases, National Institutes of Health
GHTC endorses letter urging robust funding for NIH in FY20 appropriations bill

GHTC endorsed a letter from the Ad Hoc Group for Medical Research urging House and Senate appropriators to work quickly to adopt a meaningful increase to the fiscal year 2020 (FY20) Labor, Health and Human Services, Education, and Related Agencies appropriations bill and provide a robust funding increase for the National Institutes of Health.

PDF
View All Advocacy Actions

Events

Member Event

PATH/Teresa Guillien
Using Tech Solutions to Scale Biofortification
HarvestPlus
Learn More

Member Event

PATH/Patrick McKern
Funding Global Health R&D: What's Next to Meet Public Health Needs?
Policy Cures Research
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org